The New Drug Evaluation for oral semaglutide (Rybelsus) for the treatment of type 2 diabetes mellitus is now available to stakeholders.
Updates to our Items not to be routinely prescribed (INRP) report with 20202021 Q1 data are now available online.
The antibacterial drugs report for April to June 2020 is now available.
The New Drug Evaluation for Brolucizumab for the treatment of wet age-related macular degeneration is now available to stakeholders.
The latest NCSO bulletin based on September 2020 prices is now available online for stakeholders only.
The RDTC has updated the COVID-19 QAAs No.7 (Electronic repeat dispensing advice ), and No.
Updates to our Cardiovascular, Dementia, Diabetes and Respiratory reports with 2020/2021 Q1 data are now available online.
The RDTC has updated COVID-19 QAA No 13 (Anticoagulation in cancer) with minor changes to the weblinks.
The RDTC has updated the COVID-19 QAAs No.5 (Prescribing in diabetes guidance), and No.